Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus

Binh An Diep1, Amy M Palazzolo-Ballance, Pierre Tattevin

  • 1Division of Infectious Diseases, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.

Plos One
|September 13, 2008
PubMed

Insights

Panton-Valentine leukocidin (PVL) does not affect gene regulation in community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). However, PVL contributes modestly and transiently to CA-MRSA bacteremia pathogenesis in rabbits.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains often produce Panton-Valentine leukocidin (PVL).
  • The role of PVL in CA-MRSA pathogenesis, particularly in invasive diseases like bacteremia, is not fully understood.
  • PVL is known to lyse white blood cells, suggesting a direct role in virulence.

Purpose of the Study:

  • To investigate whether PVL influences global gene regulatory networks in CA-MRSA.
  • To determine the contribution of PVL to the pathogenesis of CA-MRSA bacteremia.
  • To evaluate the impact of PVL on bacterial survival and organ seeding in a relevant animal model.

Main Methods:

  • Comparative analysis of wild-type and PVL-deletion CA-MRSA strains (USA300 and USA400).
  • Microarray and proteomic analyses to assess global gene and protein expression.
  • Development and utilization of a rabbit bacteremia model for infection studies.

Main Results:

  • PVL did not alter global gene or protein expression in CA-MRSA strains.
  • In the rabbit model, PVL conferred a modest, transient contribution to CA-MRSA bacteremia pathogenesis.
  • PVL was associated with early seeding of the kidney but this advantage was lost by 72 hours post-infection.

Conclusions:

  • PVL's contribution to CA-MRSA pathogenesis is not mediated through global gene regulatory networks.
  • PVL plays a modest and transient role in the acute phase of CA-MRSA bacteremia.
  • These findings align with the rapid-onset, severe infections associated with PVL-positive CA-MRSA strains.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...